Among Adult Patients Suffering From Anosmia in the Setting of “Long COVID,” Is the Stellate Ganglion Block an Effective Treatment for Olfactory Dysfunction When Compared to Intranasal and Systemic Corticosteroids?
Student Columbia University School of Nursing New York
Providers should consider the potential of the stellate ganglion block as a valid treatment option for COVID-19 related anosmia, although further research is necessary.
